What if cancer treatment could find and destroy cancer cells with extraordinary precision while minimizing damage to healthy tissue?In Part 2 of this special Rx for Biotech series, Dr. Babak Saboury and Dr. Eliot Siegel from United Theranostics explain radioligand therapy (RLT), one of the fastest-growing areas in precision medicine and cancer treatment.Radioligand therapies combine advanced imaging and targeted radiation to identify, track, and treat cancer cells throughout the body. This emerging field, known as theranostics, allows physicians to "see what they treat and treat what they see."In this episode, you'll learn:• What radioligand therapy (RLT) is• How theranostics works• The difference between traditional radiation and targeted radiopharmaceutical therapy• How imaging helps personalize treatment• Why prostate cancer and neuroendocrine tumor patients are benefiting today• What patients can expect during treatment• Common side effects and safety considerationsIf you or someone you love has been diagnosed with cancer, this conversation is a good educational primer to one of the most promising advances in oncology.Subscribe for more patient-focused conversations on cancer treatment, precision medicine, immunotherapy, cell therapy, and healthcare innovation.#CancerTreatment #RadioligandTherapy #Theranostics #ProstateCancer #NeuroendocrineTumors #PrecisionMedicine